Page last updated: 2024-08-21

pyrimidine and HIV Coinfection

pyrimidine has been researched along with HIV Coinfection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Dai, SX; Feng, K; Li, BX; Li, WX; Li, Y; Liu, Y; Sun, M; Zhang, H; Zheng, JJ1
Hewlett, K; Hughes, SH; Pauly, GT; Schneider, JP; Smith, SJ1
Baiget, M; de la Calle-Martín, O; Domingo, JC; Domingo, P; Fernandez, I; Gutierrez, Mdel M; Mateo, MG; Pruvost, A; Salazar, J; Torres, F; Vidal, F; Villarroya, F1
Baska, F; Bencze, G; Greff, Z; Gyuris, A; Kelemenics, K; Kéri, G; Minárovits, J; Németh, G; Orfi, L; Sipos, A; Szántai-Kis, C; Szathmáry, Z; Varga, Z1
Katti, SB; Murugesan, V; Rawal, RK1
Al-Masoudi, NA; Baqir, SJ; Jafar, NN; Leyssen, P; Pannecouque, C1

Reviews

1 review(s) available for pyrimidine and HIV Coinfection

ArticleYear
Structure-activity relationship studies on clinically relevant HIV-1 NNRTIs.
    Current medicinal chemistry, 2012, Volume: 19, Issue:31

    Topics: Benzoxazines; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Piperazines; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Triazines

2012

Other Studies

5 other study(ies) available for pyrimidine and HIV Coinfection

ArticleYear
Novel pathways of HIV latency reactivation revealed by integrated analysis of transcriptome and target profile of bryostatin.
    Scientific reports, 2020, 02-26, Volume: 10, Issue:1

    Topics: Bryostatins; CD4-Positive T-Lymphocytes; Cell Cycle Checkpoints; HIV Infections; HIV-1; Humans; Protein Kinase C; Purines; Pyrimidines; Signal Transduction; Transcriptome; Tumor Suppressor Protein p53; Up-Regulation; Virus Latency

2020
Structure-based non-nucleoside inhibitor design: Developing inhibitors that are effective against resistant mutants.
    Chemical biology & drug design, 2021, Volume: 97, Issue:1

    Topics: Anti-HIV Agents; Binding Sites; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Dynamics Simulation; Mutation; Pyridones; Pyrimidines; Rilpivirine; Triazoles

2021
Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Adult; Female; Genotype; HIV Infections; HLA-B40 Antigen; Humans; Intracellular Space; Lipodystrophy; Male; Metabolic Syndrome; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Pyrimidines; Stavudine; Thymidylate Synthase

2013
Novel, selective CDK9 inhibitors for the treatment of HIV infection.
    Current medicinal chemistry, 2011, Volume: 18, Issue:3

    Topics: Anti-HIV Agents; Binding Sites; Catalytic Domain; Cell Line; Computer Simulation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 9; HIV; HIV Infections; Humans; Protein Kinase Inhibitors; Pyrimidines; Virus Replication

2011
Exploration of the in vitro antiviral activity of a series of new pyrimidine analogues on the replication of HIV and HCV.
    Antiviral chemistry & chemotherapy, 2012, Sep-25, Volume: 23, Issue:3

    Topics: Antiviral Agents; Cell Line; Hepacivirus; Hepatitis C; HIV; HIV Infections; HIV-1; HIV-2; Humans; Pyrimidines; Structure-Activity Relationship; Virus Replication

2012